SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001235802-22-000073
Filing Date
2022-06-02
Accepted
2022-06-02 16:51:01
Documents
1
Period of Report
2022-06-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 7271
  Complete submission text file 0001235802-22-000073.txt   8758
Mailing Address TWO CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address TWO CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454
DiaMedica Therapeutics Inc. (Issuer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address
Giuffre Randall Michael (Reporting) CIK: 0001759822 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36291 | Film No.: 22991578